A Safety Study of SGN-CD19A for B-Cell Lymphoma

Clinical trial NCT01786135 · COMPLETED

Trial details

NCT number: NCT01786135
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Burkitt Lymphoma Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Start date: 2013-02-01
Primary completion: 2015-08-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.